Lobbying activity

Q2

CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS for NOVARTIS

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income

Trade (domestic/foreign), Health Issues

View → Q2

HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate

Health Issues

View → Q2

LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $30,000.00 income

Health Issues

View → Q2

LMH STRATEGIC SOLUTIONS for ALNYLAM PHARMACEUTICALS, INC.

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $50,000.00 income

Medicare/Medicaid

View → Q1

BROWNSTEIN HYATT FARBER SCHRECK, LLP for NOVARTIS

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · $90,000.00 income

Health Issues

View → Q1

AVENUE SOLUTIONS for GENENTECH USA, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $50,000.00 income

Medicare/Medicaid, Health Issues

View → Q1

TODD STRATEGY GROUP for NOVARTIS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Health Issues, Medicare/Medicaid, Trade (domestic/foreign)

View → Q1

AMGEN, INC. for AMGEN INC

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark

View → Q1

TODD STRATEGY GROUP for ASTRAZENECA PHARMACEUTICALS LP

1st Quarter (Jan 1 - Mar 31) 2026 · Delaware · House · Senate · $80,000.00 income

Medicare/Medicaid, Health Issues

View → Q1

TODD STRATEGY GROUP for ALNYLAM PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $60,000.00 income

Medicare/Medicaid

View → Q1

SPLITOAK STRATEGIES LLC for ALNYLAM PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $60,000.00 income

Medicare/Medicaid

View → Q1

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Homeland Security

View → Q1

TIBER CREEK GROUP for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS)

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Medicare/Medicaid, Health Issues, Trade (domestic/foreign)

View → Q1

ALNYLAM PHARMACEUTICALS, INC. for ALNYLAM PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate

Medicare/Medicaid, Trade (domestic/foreign), Pharmacy

View → Q1

DLA PIPER LLP (US) for NOVARTIS

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Copyright/Patent/Trademark, Taxation/Internal Revenue Code, Trade (domestic/foreign), Health Issues

View → Q1

BGR GOVERNMENT AFFAIRS for NOVARTIS

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Health Issues, Medicare/Medicaid

View → Q1

NOVARTIS for NOVARTIS

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Labor Issues/Antitrust/Workplace, Budget/Appropriations, Copyright/Patent/Trademark, Health Issues

View → Q1

PERSONALIZED MEDICINE COALITION for PERSONALIZED MEDICINE COALITION

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Health Issues

View → Q1

TROUTMAN STRATEGIES for THE MENDED HEARTS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Georgia · House · Senate · $60,000.00 income

Health Issues

View → Q1

CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS for NOVARTIS

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income

Trade (domestic/foreign), Health Issues

View → Q1

FORBES-TATE for IONIS PHARMACEUTICAL, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $30,000.00 income

Health Issues, Medicare/Medicaid

View → Q1

FORBES-TATE for NOVARTIS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income

Taxation/Internal Revenue Code, Health Issues, Medicare/Medicaid, Trade (domestic/foreign)

View → Q1

TIBER CREEK GROUP for ALNYLAM PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $60,000.00 income

Medicare/Medicaid

View → Q1

LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $30,000.00 income

Health Issues

View → Q1

LMH STRATEGIC SOLUTIONS for ALNYLAM PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $50,000.00 income

Medicare/Medicaid

View →